FN-III proteins are widely distributed in mammals and are usually involved in cellular growth, differentiation, and adhesion. The FNDC5/irisin regulates energy metabolism and is present in different tissues (liver, brain, etc.). In large mammals, the regulation of energy homeostasis under metabolic shifts is the foremost challenge to keep normal physiological and molecular functioning. Fibronectin type III domain containing 5 (FNDC5) was initially designated as a critical factor that causes cellular differentiation of skeletal muscle. Principally, it was detected in peroxisomes. Irisin is a myokine involved in higher energy expenditure through stimulation of white adipose tissues. Keeping in view the physiological roles of FN-III proteins (particularly FNDC-5), it is imperative to characterize these proteins at the genomic level to better understand their structure and putative functions in the buffalo.
Gene | Chr. | Exon Count | MW (Da) |
A.A | pI | AI | II | GRAVY |
---|---|---|---|---|---|---|---|---|
Fibronectin 1 (FN1) | 2 | 46 | 258,641.53 | 2354 | 5.28 | 69.74 | 40.09 | −0.487 |
Fibronectin type III domain containing 5 (FNDC5) | 2 | 6 | 22,869.33 | 205 | 6.44 | 92.68 | 52.30 | −0.218 |
Fibronectin type III domain containing 3B (FNDC3B) | 1 | 31 | 127,736.34 | 1160 | 5.91 | 69.91 | 53.98 | −0.434 |
Fibronectin type III and ankyrin repeat domains 1 (FANK1) | 23 | 14 | 38,413.93 | 345 | 8.51 | 89.51 | 33.76 | −0.334 |
Fibronectin type III and SPRY domain containing 1 like (FSD1L) | 3 | 16 | 58,607.09 | 521 | 6.32 | 75.93 | 46.15 | −0.574 |
Leucine-rich repeat and fibronectin type III domain containing 1 (LRFN1) | 18 | 8 | 82,023.66 | 770 | 7.89 | 90.16 | 49.73 | −0.066 |
Leucine-rich repeat and fibronectin type III domain containing 5 (LRFN5) | 20 | 8 | 52,122.68 | 466 | 6.60 | 95.47 | 35.44 | −0.141 |
Fibronectin type III and SPRY domain containing 1 (FSD1) | 9 | 13 | 55,768.58 | 662 | 4.96 | 77.88 | 48.72 | −0.380 |
Fibronectin type III domain containing 3A (FNDC3A) | 13 | 31 | 133,632.56 | 1217 | 6.44 | 71.27 | 46.88 | −0.412 |
Fibronectin type III domain containing 1 (FNDC1) | 10 | 23 | 205,865.78 | 1905 | 9.66 | 59.01 | 59.92 | −0.799 |
Leucine-rich repeat and fibronectin type III domain containing 3 (LRFN3) | 18 | 5 | 72,450.76 | 679 | 9.38 | 87.05 | 59.78 | −0.246 |
Fibronectin type III and SPRY domain containing 2 (FSD2) | 20 | 15 | 84,755.73 | 747 | 4.81 | 69.69 | 47.20 | −0.593 |
Fibronectin type III domain containing 7 (FNDC7) | 6 | 13 | 85,949.11 | 811 | 6.53 | 77.69 | 45.18 | 0.046 |
Ankyrin repeat and fibronectin type III domain containing 1 (ANKFN1) | 3 | 20 | 120,567.79 | 1068 | 6.52 | 80.73 | 58.15 | −0.467 |
Immunoglobulin like and fibronectin type III domain containing 1 (IGFN1) | 5 | 26 | 347,525.99 | 3490 | 6.49 | 55.35 | 34.98 | −0.590 |
Fibronectin type III domain containing 4 (FNDC4) | 12 | 7 | 24,753.16 | 230 | 7.66 | 88.87 | 55.08 | −0.252 |
Fibronectin type III domain containing 8 (FNDC8) | 3 | 4 | 34,298.93 | 312 | 5.29 | 80.93 | 46.44 | −0.370 |
Leucine-rich repeat and fibronectin type III domain containing 4 (LRFN4) | 5 | 3 | 66,839.10 | 636 | 6.70 | 94.14 | 42.55 | −0.028 |
Fibronectin type III domain containing protein 3C1-like (LOC102393884) | X | 27 | 157,320.54 | 1433 | 6.79 | 71.84 | 45.92 | −0.439 |
Fibronectin leucine-rich transmembrane protein 2 (FLRT2) | 11 | 4 | 73,773.40 | 660 | 7.89 | 94.18 | 36.58 | −0.185 |
EGF like, fibronectin type III and laminin G domains (EGFLAM) | 19 | 23 | 112,751.54 | 1032 | 6.53 | 74.46 | 41.70 | −0.325 |
Fibronectin type III domain containing 9 (FNDC9) | 9 | 2 | 25,342.98 | 227 | 5.65 | 85.99 | 54.56 | −0.055 |
Leucine-rich repeat and fibronectin type III domain containing 2 (LRFN2) | ||||||||
Fibronectin leucine-rich transmembrane protein 3 (FLRT3) | 14 | 3 | 73,171.75 | 649 | 7.56 | 94.18 | 44.53 | −0.296 |
Fibronectin leucine-rich transmembrane protein 1 (FLRT1) | 5 | 2 | 74,144.68 | 677 | 6.15 | 96.88 | 32.12 | −0.122 |
Fibronectin type III domain containing 11 (FNDC11) | 14 | 4 | 38,198.37 | 333 | 6.81 | 96.34 | 53.23 | −0.280 |
Fibronectin type III domain containing 10 (FNDC10) |
5 | 3 | 24,097.32 | 225 | 9.11 | 87.33 | 66.15 | 0.124 |
Extracellular leucine-rich repeat and fibronectin type III domain containing 2 (ELFN2) | 4 | 4 | 90,363.67 | 824 | 7.78 | 81.78 | 48.76 | −0.295 |
Extracellular leucine-rich repeat and fibronectin type III domain containing 1 (ELFN1) | 24 | 3 | 87,687.60 |
Motif | Protein Sequence | Length | Pfam Domain |
---|---|---|---|
808 | |||
8.82 | |||
79.43 | |||
61.89 | |||
−0.351 | |||
MEME-1 | DNFIAAIPRRDFANMTGLVDLTLSRNTISHIEAGAFDDLENLRALHLDNN | 50 | LRR_8 |
MEME-2 | NPLHCNCELLWLRRLAREDDLETCASPPGLTGRYFWSVPEEEFLCEPPLI | 50 | LRRCT |
MEME-3 | LTNLEPDTTYRLCVQALNSAG | 21 | fn3 |
MEME-4 | MVNLETLRLDHNLIDTIPPGAFSELHKLARLDLTSNRLQKL | 41 | LRR_8 |
MEME-5 | HWVAPDGRLVGNSSRTRVYPNGTLDILITTSGDSGAFTCIASNAAGEATA | 50 | I-set |
MEME-6 | CPSVCRCDRGFIYCNDRGLTSIPAGIPEDATTLYLQNNQINNAGIPADLK | 50 | LRRNT |
MEME-7 | CPKRCICQNLSPSLSTLCAKKGLLFVPPNIDRRTVELRL | 39 | Toxin_11 |
MEME-8 | WPVQRPAPGIRMYQIQYNSSADDTLVYRM | 29 | - |
MEME-9 | LEDLDLSYNNLESIPW | 16 | LRR_4 |
MEME-10 | GTEYRFRVRACNEAGEGPLSEPYTVTTPP | 29 | fn3 |
2 | |||
2 | |||
87,694.08 | |||
820 | |||
6.59 | |||
90.88 | |||
44.73 | −0.097 |
Sr. No. | Receptor | Docking Score |
Ligand RMSD (A0) |
Ligand Interacting Residues |
---|---|---|---|---|
1 | Androgen | −311.40 | 86.42 | Asn36, Thr38, Arg40 |
2 | DDB1 and CUL4 associated factor 6 | −256.63 | 79.76 | Asn36, Thr38, Arg40, His41 |
3 | Estrogen-related receptor β | −295.57 | 108.96 | Arg72, Mse73, Leu74, Arg75, Phe76, Ile77, Gln78, Glu79, Val80, Asn81, Cys87, Ala88, Trp90, Asp91 |
4 | Estrogen-related receptor γ | −256.63 | 79.76 | Arg40, His41, Lys43, Lys120, Pro122, Arg123 |
5 | Krüppel-like factor 15 | −260.71 | 81.85 | Ser30, Pro31, Arg72, Mse73, Leu74, Arg75, Phe76, Ile77, Gln78, Glu79, Asn81, Ala88, Trp90, Gln108, Pro112, Val180 |
6 | Nuclear receptor subfamily 3 group C member 1 | −308.59 | 108.34 | Lys740, Glu741, Asn742, Leu744, Leu745, Arg746, Leu748, Leu749, Asp753 |